Microbiology

  1. Nelfinavir inhibits replication of severe acute respiratory syndrome coronavirus 2 in vitro

    1. Norio Yamamoto
    2. Shutoku Matsuyama
    3. Tyuji Hoshino
    4. Naoki Yamamoto

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Genomic determinants of pathogenicity in SARS-CoV-2 and other human coronaviruses

    1. Ayal B. Gussow
    2. Noam Auslander
    3. Guilhem Faure
    4. Yuri I. Wolf
    5. Feng Zhang
    6. Eugene V. Koonin

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Coronavirus hemagglutinin-esterase and spike proteins co-evolve for functional balance and optimal virion avidity

    1. Yifei Lang
    2. Wentao Li
    3. Zeshi Li
    4. Danielle Koerhuis
    5. Arthur C.S. van den Burg
    6. Erik Rozemuller
    7. Berend-Jan Bosch
    8. Frank J.M. van Kuppeveld
    9. Geert-Jan P.H. Boons
    10. Eric G. Huizinga
    11. Hilde M. van der Schaar
    12. Raoul J. de Groot

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication

    1. Franck Touret
    2. Magali Gilles
    3. Karine Barral
    4. Antoine Nougairède
    5. Etienne Decroly
    6. Xavier de Lamballerie
    7. Bruno Coutard

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Atazanavir, Alone or in Combination with Ritonavir, Inhibits SARS-CoV-2 Replication and Proinflammatory Cytokine Production

    1. Natalia Fintelman-Rodrigues
    2. Carolina Q. Sacramento
    3. Carlyle Ribeiro Lima
    4. Franklin Souza da Silva
    5. André C. Ferreira
    6. Mayara Mattos
    7. Caroline S. de Freitas
    8. Vinicius Cardoso Soares
    9. Suelen da Silva Gomes Dias
    10. Jairo R. Temerozo
    11. Milene D. Miranda
    12. Aline R. Matos
    13. Fernando A. Bozza
    14. Nicolas Carels
    15. Carlos Roberto Alves
    16. Marilda M. Siqueira
    17. Patrícia T. Bozza
    18. Thiago Moreno L. Souza

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. LY6E Restricts the Entry of Human Coronaviruses, including the currently pandemic SARS-CoV-2

    1. Xuesen Zhao
    2. Shuangli Zheng
    3. Danying Chen
    4. Mei Zheng
    5. Xinglin Li
    6. Guoli Li
    7. Hanxin Lin
    8. Jinhong Chang
    9. Hui Zeng
    10. Ju-Tao Guo

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Indomethacin has a potent antiviral activity against SARS CoV-2 in vitro and canine coronavirus in vivo

    1. Tianhong Xu
    2. Xuejuan Gao
    3. Zengbin Wu
    4. Douglas W. Selinger
    5. Zichen Zhou

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Increasing testing throughput and case detection with a pooled-sample Bayesian approach in the context of COVID-19

    1. Rodrigo Noriega
    2. Matthew H. Samore

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. SARS-CoV-2 and SARS-CoV differ in their cell tropism and drug sensitivity profiles

    1. Denisa Bojkova
    2. Jake E. McGreig
    3. Katie-May McLaughlin
    4. Stuart G. Masterson
    5. Marek Widera
    6. Verena Krähling
    7. Sandra Ciesek
    8. Mark N. Wass
    9. Martin Michaelis
    10. Jindrich Cinatl

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Potent Antiviral Activities of Type I Interferons to SARS-CoV-2 Infection

    1. Emily Mantlo
    2. Natalya Bukreyeva
    3. Junki Maruyama
    4. Slobodan Paessler
    5. Cheng Huang

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 73 of 251 Next